Plasma
Showing all 15 results
Cystic Fibrosis Plasma
Cystic Fibrosis Plasma – Cryopreserved human cycstic fibrosis plasma collected from clinically confirmed cystic fibrosis donors. Cystic Fibrosis plasma is ideal for inflammation studies, cytokine profiling, and biomarker research.
Down Syndrome Plasma
Down Syndrome Plasma samples are collected from donors diagnosed with Down syndrome. Suitable for profiling cytokines, metabolic markers, and proteins linked to accelerated aging and comorbidities such as Alzheimer’s disease.
Fabry Disease Plasma
Fabry Disease Plasma – Cryopreserved human plasma collected from clinically confirmed Fabry Disease donors. Fabry Disease plasma is ideal for metabolic biomarkers for understanding disease progression.
Facioscapulohumeral Muscular Dystrophy Plasma
Facioscapulohumeral Muscular Dystrophy Plasma samples are collected from donors diagnosed with facioscapulohumeral muscular dystrophy (FSHD). Suitable for analyzing muscle damage biomarkers, proinflammatory cytokines, and circulating proteins linked to disease activity and progression.
Friedreich’s Ataxia Plasma
Friedreich’s Ataxia Plasma samples are collected from donors diagnosed with Friedreich’s Ataxia. Suitable for analyzing metabolic abnormalities, markers of oxidative damage, and circulating proteins linked to mitochondrial impairment and disease progression.
Gaucher’s Disease Plasma
Gaucher’s Disease Plasma samples are collected from donors diagnosed with Gaucher’s disease. Suitable for analyzing biomarkers such as chitotriosidase, CCL18, and glucosylsphingosine (Lyso-Gb1), which reflect disease activity and treatment response.
Huntington’s Disease Plasma
Huntington’s Disease Plasma – Cryopreserved human plasma collected from clinically confirmed Huntington’s Disease donors. Huntington’s Disease plasma is ideal for investigating circuating biomarkers and disesase progression.
Mucopolysaccharidosis Plasma
Mucopolysaccharidosis Plasma samples are collected from donors diagnosed with Mucopolysaccharidosis (MPS). Suitable for analyzing GAG levels, enzyme deficiencies, and circulating biomarkers relevant to disease burden and therapeutic monitoring.
Myotonic Dystrophy Plasma
Myotonic Dystrophy Plasma samples are collected from donors diagnosed with Myotonic Dystrophy (DM). Suitable for analyzing circulating RNA-binding proteins, metabolic biomarkers, and indicators of cardiac and endocrine complications.
PFIC Plasma
PFIC Plasma samples are collected from donors diagnosed with Progressive Familial Intrahepatic Cholestasis (PFIC). Suitable for analyzing bile acid profiles, liver injury markers, and cytokines associated with disease severity and progression in PFIC.
Pompe Disease Plasma
Pompe Disease Plasma samples are collected from donors diagnosed with Pompe Disease (PD). Suitable for analyzing biomarkers of muscle damage, metabolic dysfunction, and systemic inflammation associated with PD progression and therapy response.
Sickle Cell Disease Plasma
Sickle Cell Disease Plasma – Cryopreserved human sickle cell disease plasma collected from clinically confirmed sickle cell disease donors. Sickle Cell Disease plasma is ideal for analysis of hemolysis biomarkers, oxidative stress, inflammation, and coagulation abnormalities.
Sickle Cell Trait Plasma
Sickle Cell Trait Plasma – Cryopreserved human sickle cell trait plasma collected from clinically confirmed sickle cell trait (HbAS) donors. Sickle Cell Trait plasma is ideal for markers of low-grade hemolysis, oxidative stress, and endothelial activation.
Spinal Muscular Atrophy Plasma
Spinal Muscular Atrophy Plasma samples are collected from donors diagnosed with Spinal Muscular Atrophy (SMA). Suitable for analyzing neurodegenerative biomarkers, inflammatory cytokines, and metabolic indicators associated with motor neuron loss in SMA.
Stargardt Disease Plasma
Stargardt Disease Plasma samples are collected from donors diagnosed with Stargardt Disease (STGD). Suitable for analyzing circulating inflammatory markers, oxidative stress indicators, and lipid metabolism profiles associated with retinal degeneration in STGD.